NeuroBasic PharmaPhenomics is a research consortium with several academic and commercial partners that builds on the successes of Neuro-Bsik. It aims to develop new drug discovery strategies in both neurology and psychiatry. They use a novel approach; improving early stage drug development with so called pharma-phenomics, well-characterized genetic animal models and response classification systems. The project is funded by the Dutch science ministry and VU Amsterdam.
Subsidy: approximately € 13.500.000,-
i3B partners: Noldus IT, Wageningen UR,
Website: click here
Status: finalised January, 2016